A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

PHASE3CompletedINTERVENTIONAL
Enrollment

449

Participants

Timeline

Start Date

August 22, 2017

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Partial Seizures With or Without Secondary GeneralizationEpilepsy
Interventions
DRUG

Placebo

"* Pharmaceutical form: Film-coated tablets~* Route of administration: Oral use"

DRUG

Brivaracetam

"* Pharmaceutical form: Film-coated tablets~* Concentration: 25 mg tablets and 50 mg tablets~* Route of administration: Oral use"

Trial Locations (94)

Unknown

Ep0083 905, Beijing

Ep0083 906, Beijing

Ep0083 907, Changchun

Ep0083 901, Chengdu

Ep0083 902, Guangzhou

Ep0083 909, Guangzhou

Ep0083 917, Guangzhou

Ep0083 920, Guangzhou

Ep0083 922, Guangzhou

Ep0083 924, Guangzhou

Ep0083 912, Hangzhou

Ep0083 908, Lanzhou

Ep0083 921, Nanchang

Ep0083 926, Pingxiang

Ep0083 910, Shijiazhuang

Ep0083 925, Suzhou

Ep0083 913, Wenzhou

Ep0083 927, Xi'an

Ep0083 930, Xinxiang

Ep0083 916, Yinchuan

Ep0083 918, Zhanjiang

Ep0083 904, Zhengzhou

Ep0083 923, Zunyi

Ep0083 148, Adachi-ku

Ep0083 116, Asaka

Ep0083 126, Bunkyō City

Ep0083 127, Bunkyō City

Ep0083 146, Chiba

Ep0083 122, Hachinohe

Ep0083 111, Hamamatsu

Ep0083 141, Higashisonogi-gun Kawatana-cho

Ep0083 110, Hiroshima

Ep0083 121, Itami

Ep0083 102, Kagoshima

Ep0083 142, Kamakura

Ep0083 140, Kawasaki

Ep0083 123, Kodaira

Ep0083 115, Kokubunji

Ep0083 132, Kōriyama

Ep0083 112, Kōshi

Ep0083 128, Kurume

Ep0083 124, Kyoto

Ep0083 147, Kyoto

Ep0083 105, Nagakute

Ep0083 118, Nagoya

Ep0083 136, Nagoya

Ep0083 117, Nara

Ep0083 129, Neyagawa

Ep0083 106, Niigata

Ep0083 130, Ôsaka

Ep0083 131, Ōtsu

Ep0083 114, Saitama

Ep0083 101, Sapporo

Ep0083 103, Sendai

Ep0083 144, Shinjuku-ku

Ep0083 104, Shizuoka

Ep0083 108, Suita

Ep0083 137, Suita

Ep0083 138, Tsukuba

Ep0083 133, Ushiku

Ep0083 109, Yamagata

Ep0083 120, Yokohama

Ep0083 150, Yokohama

Ep0083 207, Kota Bharu

Ep0083 201, Kuala Lumpur

Ep0083 206, Kuala Terengganu

Ep0083 204, Kuching

Ep0083 209, Miri

Ep0083 202, Perai

Ep0083 208, Pulau Pinang

Ep0083 203, Sungai Buloh

Ep0083 303, Cebu City

Ep0083 304, Cebu City

Ep0083 306, Davao City

Ep0083 307, Iloilo City

Ep0083 301, Manila

Ep0083 302, Manila

Ep0083 310, Manila

Ep0083 309, Quezon City

Ep0083 401, Singapore

Ep0083 402, Singapore

Ep0083 502, Chiayi City

Ep0083 505, Kaohsiung City

Ep0083 503, Taichung

Ep0083 504, Taichung

Ep0083 501, Tainan City

Ep0083 602, Bangkok

Ep0083 605, Bangkok

Ep0083 606, Bangkok

Ep0083 607, Bangkok

Ep0083 609, Bangkok

Ep0083 601, Khon Kaen

Ep0083 603, Muang

Ep0083 608, Muang

All Listed Sponsors
lead

UCB Biopharma SRL

INDUSTRY

NCT03083665 - A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy | Biotech Hunter | Biotech Hunter